Alterations in the immuno-skeletal interface drive bone destruction in HIV-1 transgenic rats

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 31, 2010, Pages 13848-13853

  Vikulina, Tatyana ^a   Fan, Xian ^a,b   Yamaguchi, Masayoshi ^a   Roser Page, Susanne ^b   Zayzafoon, Majd ^c   Guidot, David M ^a,b   Ofotokun, Ighovwerha ^a   Weitzmann, M Neale ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ATLANTA VA MEDICAL CENTER   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

AIDS; Osteoclast; Osteoporosis; Osteoprotegerin; Receptor activator of NF B ligand

Indexed keywords

OSTEOPROTEGERIN; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; OSTEOCLAST DIFFERENTIATION FACTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BONE DENSITY; BONE DESTRUCTION; BONE MASS; BONE STRUCTURE; CELL COUNT; CONTROLLED STUDY; DISEASE SEVERITY; HUMAN IMMUNODEFICIENCY VIRUS 1; MALE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; RAT; TRANSGENIC RAT; ANIMAL; BIOSYNTHESIS; FISCHER 344 RAT; IMMUNOLOGY; METABOLISM; PATHOPHYSIOLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1; RATTUS;

ANIMALS; B-LYMPHOCYTES; BONE DENSITY; BONE RESORPTION; HIV-1; MALE; RANK LIGAND; RATS; RATS, INBRED F344; RATS, TRANSGENIC;

EID: 77956378534     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1003020107     Document Type: Article

References (32)

1. Li Y, et al. (2007) B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo. Blood 109:3839-3848.
2. Weitzmann MN, Pacifici R (2006) Estrogen deficiency and bone loss: An inflammatory tale. J Clin Invest 116:1186-1194.
3. Eghbali-Fatourechi G, et al. (2003) Role of RANK ligand in mediating increased bone resorption in early postmenopausal women. J Clin Invest 111:1221-1230.
4. Deeks SG (2009) Immune dysfunction, inflammation, and accelerated aging in patients on antiretroviral therapy. Top HIV Med 17:118-123.
5. Nguyen N, Holodniy M (2008) HIV infection in the elderly. Clin Interv Aging 3:453-472.
6. Thomas J, Doherty SM (2003) HIV infection - a risk factor for osteoporosis. J Acquir Immune Defic Syndr 33:281-291.
7. Guaraldi G, et al. (2001) Pathological fractures in AIDS patients with osteopenia and osteoporosis induced by antiretroviral therapy. AIDS 15:137-138.
8. Triant VA, Brown TT, Lee H, Grinspoon SK (2008) Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system. J Clin Endocrinol Metab 93:3499-3504.
9. Yin MT, et al. (2010) Low bone mass and high bone turnover in postmenopausal human immunodeficiency virus-infected women. J Clin Endocrinol Metab 95:620-629.
10. Johnell O, Kanis JA (2006) An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 17:1726-1733.
11. Lewis JR, Hassan SK, Wenn RT, Moran CG (2006) Mortality and serum urea and electrolytes on admission for hip fracture patients. Injury 37:698-704.
12. Teitelbaum SL (2000) Bone resorption by osteoclasts. Science 289:1504-1508.
13. Choi Y, et al. (2001) Osteoclastogenesis is enhanced by activated B cells but suppressed by activated CD8(+) T cells. Eur J Immunol 31:2179-2188.
14. Kawai T, et al. (2006) B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease. Am J Pathol 169:987-998.
15. Yun TJ, et al. (1998) OPG/FDCR-1, a TNF receptor family member, is expressed in lymphoid cells and is up-regulated by ligating CD40. J Immunol 161:6113-6121.
16. Moir S, Fauci AS (2009) B cells in HIV infection and disease. Nat Rev Immunol 9:235-245.
17. Mondy K, et al. (2003) Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus-infected individuals. Clin Infect Dis 36:482-490.
18. Reid W, et al. (2001) An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction. Proc Natl Acad Sci USA 98:9271-9276.
19. Reid W, et al. (2004) HIV-1 transgenic rats develop T cell abnormalities. Virology 321:111-119.
20. Lassiter C, et al. (2009) HIV-1 transgene expression in rats causes oxidant stress and alveolar epithelial barrier dysfunction. AIDS Res Ther 6:1.
21. Cenci S, et al. (2000) Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha. J Clin Invest 106:1229-1237.
22. Lam J, et al. (2000) TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest 106:1481-1488.
23. Zhang YH, Heulsmann A, Tondravi MM, Mukherjee A, Abu-Amer Y (2001) Tumor necrosis factor-alpha (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways. J Biol Chem 276:563-568.
24. Haine V, Fischer-Smith T, Rappaport J (2006) Macrophage colony-stimulating factor in the pathogenesis of HIV infection: Potential target for therapeutic intervention. J Neuroimmune Pharmacol 1:32-40.
25. Takeda S, et al. (2002) Leptin regulates bone formation via the sympathetic nervous system. Cell 111:305-317.
26. Moir S, et al. (2008) Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals. J Exp Med 205:1797-1805.
27. Morrow M, Valentin A, Little R, Yarchoan R, Pavlakis GN (2008) A splenic marginal zone-like peripheral blood CD27+B220- B cell population is preferentially depleted in HIV type 1-infected individuals. AIDS Res Hum Retroviruses 24:621-633.
28. Kim WK, et al. (2009) Monocyte heterogeneity underlying phenotypic changes in monocytes according to SIV disease stage. J Leukoc Biol 87:557-567.
29. Hasegawa A, et al. (2009) The level of monocyte turnover predicts disease progression in the macaque model of AIDS. Blood 114:2917-2925.
30. Kim SY, Solomon DH (2010) Tumor necrosis factor blockade and the risk of viral infection. Nat Rev Rheumatol 6:165-174.
31. Borderi M (2006) Multifactorial relations between HIV, HAART and bone metabolism. Infez Med 14:117-124.
32. Tebas P, et al. (2000) Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy. AIDS 14:F63-F67.